Evidence map›Paper›PMID 39365048›Full record

ArticleApplied and environmental microbiology2024

A realistic approach for evaluating antimicrobial surfaces for dry surface exposure scenarios.

Yi Enn Cheong, Ralph Weyandt, Wilma Dewald, Timo Tolksdorf, Laura Müller, Armin Braun

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Bacteriophage-Based Control of Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yi Enn CheongVolkswagen AG, Group Innovation, Wolfsburg, Germany.ORCID 0009-0005-6793-6182
Ralph WeyandtBioservices Department, SGS Institut Fresenius GmbH, Taunusstein, Germany.
Wilma DewaldVolkswagen AG, Group Innovation, Wolfsburg, Germany.
Timo TolksdorfVolkswagen AG, Group Innovation, Wolfsburg, Germany.
Laura MüllerPreclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine - Hannover (Germany), Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) research network Hannover (Germany), Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD) and Institute of Immunology, Medizinische Hochschule Hannover, Hannover, Germany.
Armin BraunPreclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine - Hannover (Germany), Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) research network Hannover (Germany), Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD) and Institute of Immunology, Medizinische Hochschule Hannover, Hannover, Germany.

Funding

Volkswagen Aktiengesellschaft (Volkswagen AG)
6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 pandemic has raised public awareness about the importance of hygiene, leading to an increased demand for antimicrobial surfaces to minimize microbial contamination on high-touch surfaces. This is particularly relevant in public and private transportation settings, where surfaces frequently touched by individuals pose a significant, yet preventable, risk of infection transmission. Typically, the antimicrobial activity of surfaces is tested using test methods of the International Standards Organization, American Society for Testing and Materials, or Japanese Industrial Standards, which involve complete submersion in liquid, elevated temperature (37°C), and prolonged (24 h) contact periods. However, these conditions do not accurately represent real-world scenarios where surfaces are exposed to air. In this study, we propose a modified test method designed to better reflect real-life conditions in the intended end-use setting. The modifications included using deionized water instead of nutrient broth while preparing bacterial inoculum, applying a small test inoculum to the surface and allowing it to dry, maintaining ambient temperature and relative humidity throughout the contact period, and reducing the contact period to 4 h. With this modified approach, the antimicrobial activity of 20 samples was reassessed. This screening revealed that out of 20 samples, only 2 samples were effective against all species, while 8 samples demonstrated partial effectiveness against selected species, and 10 samples showed no significant effect. These findings highlight the inadequacy of the current test standard and emphasize the urgent necessity for revised and adapted testing method to ensure a reliable and accurate evaluation.IMPORTANCEThe recent severe acute respiratory syndrome coronavirus 2 pandemic has sparked increased demand for antimicrobial surfaces to mitigate the risk of fomites-transmitted infection in both indoors and confined spaces. Commonly, the antimicrobial activity of these surfaces is assessed using test standards established by national standards bodies, which do not distinguish between different application scenarios. While these test standards are suitable for surfaces intended for submerged application, they are inappropriate for antimicrobial surfaces designed for dry surface exposure. The usage of these standards can lead to an overestimation of antimicrobial efficacy. Thus, this study introduces a modified dry exposure test method aimed at better reflecting real-life conditions in the intended end-use setting. Our results revealed the subpar antimicrobial performance of numerous samples, highlighting the necessity to revise and tailor the universal test standard to real-world scenarios in order to ensure a reliable and accurate evaluation.

Indexed as

COVID-19Anti-Infective AgentsBacteriaHumansSARS-CoV-2Surface PropertiesAnti-Infective Agentsantibacterialantimicrobialantimicrobial activityantimicrobial coatingantiviral agentsefficacy testingfomite-transmitted infectionrealistic conditionreal-life scenariossurface coating

Identifiers

PMID39365048
PMCPMC11497783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.